Natalie Callander, MD, presents a case of a 68-year-old man with multiple myeloma and reviews first-line treatment options.
A 68-Year-Old Man with Multiple Myeloma
Dr. Natalie Callander provides insight on selection of second-line therapy after transplant patients with multiple myeloma.
An expert in multiple myeloma talks through the considerations for treatment selection in the third line for patient with multiple myeloma.
Dr. Natalie Callander describes promising new treatment approaches for patients with multiple myeloma.
An expert in multiple myeloma provides clinical pearls for disease management from initial diagnosis through multiple lines of therapy.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
